Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8236873 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 6 Pages |
Abstract
The results of our study have shown that Skp2 expression is frequent in NPC and has a wide range of distribution in H-score. Skp2 overexpression is significantly predictive of DMF survival and OS, independent of the T stage and/or older age. Therefore, Skp2 might represent a useful prognostic adjunct to risk stratify NPC patients for appropriate allocation of adjuvant therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Fu-Min M.D., Ph.D., Chih-Yen M.D., Chien-Feng M.D., Wan-Yu M.S., Chang-Han Ph.D., Hsuan-Ying M.D.,